Fermentation Sparks a New Wave of US Protein Innovation

Superbrewed Food and Fonterra form a global partnership with strong US relevance as fermentation protein tech advances

19 Nov 2025

A powerful shift is unfolding in the global protein landscape as Superbrewed Food and Fonterra have formed a partnership to bring a new class of fermentation-based protein to the US market, following regulatory clearance that positions the ingredient for commercial use by American food companies.

Superbrewed recently received a “no questions” letter from the US Food and Drug Administration, confirming the agency had no objections to the safety assessment of its cultured protein. The ingredient, made through microbial fermentation rather than conventional farming, offers a nutrient profile comparable to traditional protein sources.

The agreement with Fonterra gives Superbrewed access to one of the world’s largest ingredient suppliers as it seeks to move from laboratory development to scaled production. The companies aim to accelerate adoption among manufacturers looking for alternatives to both meat and plant-based formulations.

Industry analysts say the alliance signals growing interest in technologies that can supply high-quality protein without increasing pressure on global agricultural systems. One observer described the deal as evidence that “major players are ready to treat fermentation as a core platform for next-generation nutrition”.

Fermentation-derived ingredients have drawn attention for their potential to provide stable output, lower environmental impact and functional properties that can support a range of food applications. The collaboration may prompt further partnerships between established food groups and early-stage technology companies, broadening the range of proteins available to manufacturers.

Commercialisation, however, is still at an early stage. Large-scale production is under development and initial product launches are expected in early 2025. Market acceptance will depend on consumer response as well as future regulatory decisions in the US and other jurisdictions.

Even so, the combination of a novel protein technology and a global supplier with established manufacturing and distribution networks provides the venture with a strong platform as fermentation-based proteins move closer to mainstream use.